Apr 06

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Announces Uplist to the OTCQB Venture Market

Shareholders to benefit from greater transparency and improved liquidity on OTCQB

Mar 15

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Concludes its Annual Audit with MaloneBailey, LLP

Achieving major milestone squarely positions the Company for uplisting to the OTCQB® Venture Market

Jan 18

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. Concludes its Special Meeting of Stockholders

Commanding shareholder approval better positions management to attain enterprise business objectives going forward.

Jan 04

Cardiac Biotech

Cardiac Biotech

CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022

Agenda includes transformational matters affecting the Company’s position to manage impending growth

Dec 14

Cardiac Biotech

Cardiac Biotech

Entered Beta-testing Phase for Updated Proprietary myCam Cardiac Event Monitor

Updates to provide device improvements while maintaining the innovative core-functionality of CBSC's state of the art cardiac event monitor.

Dec 07

Cardiac Biotech

Cardiac Biotech

Executed Manufacturing Letter of Intent with Shenzhen Pump Medical System Co., Ltd.

Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.

Nov 30

Cardiac Biotech

Cardiac Biotech

Announcing Intent to Convene a Special Meeting of the Stockholders

Agenda to include matters necessary to better position the company for anticipated growth and development.

Nov 16

Cardiac Biotech

Cardiac Biotech

Application Filed to Uplist to the OTCQB Venture Market

Upgraded listing would provide increased transparency and enhanced trading efficiency.

Nov 02

Cardiac Biotech

Cardiac Biotech

Announcing The Addition of Brooke Martellaro as Chief Financial Officer

Seasoned finance executive and business leader to add significant incremental competencies to the Company’s executive management team.

Oct 28

Cardiac Biotech

Cardiac Biotech

Paul Danner Appointed As Chairman

The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated success.

Looking for quarterly reports? View our financial statements.

Continue

© 2020-2025. Cardiac Biotech Solutions, Inc. - All rights reserved. | Designer

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.